Kestrel Group (NASDAQ:KG) reported quarterly losses of $(1.55) per share. This is a 0.64 percent increase over losses of $(1.56) per share from the sa...
A struggling media giant is making an unusual financial gamble.
Cadre Holdings reported Q3 2026 sales of US$202.88 million and net income of US$15.99 million, raised full year 2026 net sales guidance to a range of ...
Despite macroeconomic uncertainty, recovery in demand for certain real estate property types and constrained supply poise Real Estate Development indu...
Global Self Storage (NASDAQ:SELF) reported quarterly earnings of $0.10 per share. This is unchanged from the same period last year. The company repor...
Crane (CR) is back in focus after raising its full year 2026 earnings guidance, following third quarter results that showed higher revenue, firmer ear...
Snap-on missed earnings, watched franchisee sales sink, and saw credit delinquencies climb. Yet its board still did something it had never done before...
InvenTrust Properties (IVT) moved into focus after management lifted its 2026 net income guidance while reporting third quarter earnings per share of ...
New guideline recognition is fueling this stroke device maker's commercial expansion.
Conway runs at 40% capacity, with a path toward far higher utilization ahead.
Agent productivity rose even as legal costs and high mortgage rates weighed on results.
Management outlined a revised UK submission strategy and early named patient access plans for Ebstracel.
Chamonix cost cuts and refinancing delays tested management's outlook this quarter.
Auto insurance dragged results while loans drove growth.
Cost cuts doubled adjusted EPS despite softer sales and streaming pressure.
Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. This ...
Simon raised its 2026 Real Estate FFO outlook and its quarterly dividend to $2.30 after Q3 FFO climbed 4.7% to $3.37 per share.
Citigroup analyst Jason Bazinet maintains Unity Software (NYSE:U) with a Buy and raises the price target from $48 to $59.
Oscar Health (OSCR) just delivered a profitable third quarter and lifted its full year 2026 outlook, putting fresh attention on how this fast growing ...
Loading...